Trade Summary

2 months ago, Cherington Charles, serving as 10% owner at Ernexa Therapeutics Inc. (ERNA), purchased 4,000,000 shares at $0.50 per share, for a total transaction value of $2,000,000.00. Following this transaction, Cherington Charles now holds 6,779,440 shares of ERNA.

This purchase represents a 144.00% increase in Cherington Charles's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, February 10, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, February 17, 2026, 7 days after the trade was made.

Ernexa Therapeutics Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.